Thomas Litman

Thomas Litman

Thomas Litman works as a senior research scientist at LEO Pharma, where he is responsible for implementing bioinformatics in translational research. He has taught biophysics and transport physiology at the University of Copenhagen since 1994 and is the author of some 70 papers, most of which focus on multidrug resistance and functional characterization of drug transporters, such as P-glycoprotein. In particular the papers on transport kinetics of anticancer drugs, written together with his mentor, Professor Wilfred Stein, have been recognized as exemplary in the field. He completed his post-doctoral work at The National Cancer Institute, NIH 1997-9, where he played a key role in the identification and characterization of a new transporter, ABCG2 (MXR), involved in multidrug resistance. In 2002 he was appointed as Weimann associate research professor, and 2003-6 he was responsible for the master’s program in medical bioinformatics at the Bioinformatics Centre, University of Copenhagen. His interests range from basic and translational research to information technology and applied bioinformatics, including confocal microscopy, microarray analysis, noncoding RNA, proteomics, next-generation sequencing, and molecular modeling.

Affiliations and Expertise

Molecular Biomedicine, LEO Pharma, Ballerup, Denmark